Answers are grounded in this paper and cite their sources.
Systems allowing label-free molecular detection are expected to have enormous impact on biochemical sciences. Research focuses on materials and technologies based on exploiting localized surface plasmon resonances in metallic nanostructures. The reason for this focused attention is their suitability for single-molecule sensing, arising from intrinsically nanoscopic sensing volume and the high sensitivity to the local environment. Here we propose an alternative route, which enables radically improved sensitivity compared with recently reported plasmon-based sensors. Such high sensitivity is achieved by exploiting the control of the phase of light in magnetoplasmonic nanoantennas. We demonstrate a manifold improvement of refractometric sensing figure-of-merit. Most remarkably, we show a raw surface sensitivity (that is, without applying fitting procedures) of two orders of magnitude higher than the current values reported for nanoplasmonic sensors. Such sensitivity corresponds to a mass of ~0.8 ag per nanoantenna of polyamide-6.6 (n=1.51), which is representative for a large variety of polymers, peptides and proteins. Ferromagnetic nanoantennas support plasmons and exhibit magneto-optical activity under external magnetic fields. Maccaferri et al. show how designed phase compensation in the electric response of these nanostructures enables them to act as ultrasensitive label-free molecular sensors with high figures of merit.
No takes yet. Share an insight, caveat, or question.
Maccaferri et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: